Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,435 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Completed

Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)

NCT02301156

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
  • TG Therapeutics Investigational Trial Site Mobile, Alabama, United States
  • TG Therapeutics Investigational Trial Site Chandler, Arizona, United States
  • TG Therapeutics Investigational Trial Site Tucson, Arizona, United States
View all 88 locations
View Trial Details
Completed

Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab in the Clinical Practice: a GIMEMA-ERIC Study

NCT03545035

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • AOU Arcispedale S.Anna - UOC Ematologia e fisiopatologia della coagulazione Cona, Ferrara, Italy
  • Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia Alessandria, Italy
  • Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona- Sod Clinica Ematologica Ancona, Italy
  • Area Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia Ascoli Piceno, Italy
View all 38 locations
View Trial Details
Completed

The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib

NCT03528941

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Lymphocytic Leukemia, +25 more
Locations
  • AOU Arcispedale S.Anna - UOC Ematologia e fisiopatologia della coagulazione Cona, Ferrara, Italy
  • AOU Consorziale Policlinico - UO Ematologia con Trapianto Bari, Italy
  • ASST degli Ospedali Civili di Brescia - UO Ematologia Brescia, Italy
  • AO Brotzu, Presidio Ospedaliero A.Businco - SC Ematologia e CTMO Cagliari, Italy
View all 23 locations
View Trial Details
Completed

Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation

NCT01455051

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Hospital Germans Trias i Pujol Badalona, Spain
  • Hospital de la Santa Creu Sant Pau Barcelona, Spain
  • Hospital Vall d'Hebron Barcelona, Spain
  • Institut Catala d'Oncologia L'Hospitalet de Llobregat, Spain
View Trial Details
Completed

Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)

NCT00951457

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie Innsbruck, Tyrol, Austria
  • Landeskrankenhaus Feldkirch Feldkirch, Austria
  • A.ö. Landeskrankenhaus Leoben Leoben, Austria
  • Krankenhaus der Elisabethinen Linz Linz, Austria
View Trial Details
Completed

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

NCT01328626

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 52902 Tucson, Arizona, United States
  • Ucsd /Id# 48325 La Jolla, California, United States
  • Dana-Farber Cancer Institute /ID# 48324 Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center /ID# 56810 New York, United States
View Trial Details

Related conditions